Department of Pathology, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Am J Surg Pathol. 2013 May;37(5):659-68. doi: 10.1097/PAS.0b013e31828706c0.
Although the incidence of human papillomavirus (HPV)-associated anal neoplasia is increasing, interobserver and intraobserver reproducibility in the grading of biopsy specimens from this area remains unacceptably low. Attempts to produce a more reproducible grading scheme have led to the use of biomarkers for the detection of high-risk HPV (HR-HPV). We evaluated the performance of standard morphology and biomarkers p16, ProEx C, and Ki-67 in a set of 75 lesions [17 nondysplastic lesions, 23 low-grade squamous intraepithelial lesions (LSIL)/condyloma, 20 high-grade squamous intraepithelial lesions (HSIL), 15 invasive squamous cell carcinomas] from the anal and perianal region in 65 patients and correlated these findings with HPV subtype on the basis of a type-specific multiplex real-time polymerase chain reaction assay designed to detect HR-HPV. A subset of cases with amplifiable HPV DNA was also sequenced. HSIL was typically flat (15/20), and only a minority (4/20) had koilocytes. In contrast, only 1 LSIL was flat (1/23), and the remainder were exophytic. The majority of LSIL had areas of koilocytic change (20/23). HR-HPV DNA was detected in the majority (89%) of invasive carcinomas and HSIL biopsies, 86% and 97% of which were accurately labeled by strong and diffuse block-positive p16 and ProEx C, respectively. LSIL cases, however, only infrequently harbored HR-HPV (13%); most harbored low-risk HPV (LR-HPV) types 6 and 11. Within the LSIL group, p16 outperformed ProEx C, resulting in fewer false-positive cases (5% vs. 75%). Ki-67 was also increased in HR-HPV-positive lesions, although biopsies with increased inflammation and reactive changes also showed higher Ki-67 indices. These data suggest that strong and diffuse block-positive nuclear and cytoplasmic labeling with p16 is a highly specific biomarker for the presence of HR-HPV in anal biopsies and that this finding correlates with high-grade lesions.
尽管人乳头瘤病毒(HPV)相关肛门肿瘤的发病率正在上升,但该区域活检标本的观察者间和观察者内可重复性仍然低得令人无法接受。为了提高分级的可重复性,人们尝试使用生物标志物来检测高危型 HPV(HR-HPV)。我们评估了标准形态学和生物标志物 p16、ProEx C 和 Ki-67 在 65 名患者的 75 个病变[17 个非发育不良病变、23 个低级别鳞状上皮内病变(LSIL)/尖锐湿疣、20 个高级别鳞状上皮内病变(HSIL)、15 个浸润性鳞状细胞癌]中的性能,并根据针对 HR-HPV 的特异性多重实时聚合酶链反应检测方法,将这些发现与 HPV 亚型相关联。还对可扩增 HPV DNA 的病例进行了亚组测序。HSIL 通常为扁平状(20/20),仅有少数(4/20)有空泡细胞。相比之下,仅有 1 个 LSIL 为扁平状(23/23),其余为外生性。大多数 LSIL 都有空泡细胞改变区域(23/23)。大多数(89%)浸润性癌和 HSIL 活检均检测到 HR-HPV DNA,其中 86%和 97%的病例分别通过强而弥漫的 p16 和 ProEx C 阳性的块状染色准确标记。然而,LSIL 病例仅偶尔携带 HR-HPV(13%);大多数携带低危型 HPV(LR-HPV)6 和 11 型。在 LSIL 组中,p16 的表现优于 ProEx C,导致假阳性病例更少(5%比 75%)。Ki-67 在 HR-HPV 阳性病变中也增加,尽管伴有炎症和反应性改变的活检也显示出更高的 Ki-67 指数。这些数据表明,在肛门活检中,p16 呈强而弥漫的核和细胞质阳性块状染色是 HR-HPV 存在的高度特异性生物标志物,并且该发现与高级别病变相关。